Commercial production of plant-derived drugs
Start with the big picture
The production pathway begins with botanical authentication and selection of cultivars or chemotypes suited to the desired metabolite profile and growing conditions. Good Agricultural and Collection Practices, controlled cultivation, and appropriately timed harvesting support reliable raw material. Cleaning, drying, and primary processing help limit losses before extraction methods are chosen according to the material and production needs. Purification, analytical testing, and standardization then assess identity, marker content, and potency. The broader lesson also covers biotechnological production, metabolic engineering, regulatory compliance, pharmacovigilance, and sustainability. Together, these stages show how agricultural, processing, analytical, and oversight decisions contribute to consistent plant-derived drug production.
What you'll learn
- Describe how authentication and cultivar selection support botanical raw-material quality.
- Explain how cultivation, pre-harvest treatments, and harvest timing affect production.
- Outline post-harvest handling, extraction, and purification stages.
- Identify the roles of analytical quality control and standardization.
- Recognize biotechnology, compliance, pharmacovigilance, and sustainability as broader production considerations.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
